The Surprise Knee Ledger

Straight answers about a sore knee

Surprise courses and courts bring up the same knee questions

You want to know why the knee is sore and what may help. These answers stay close to that. This page can't check the swelling, strength, or exact sore spot. A doctor or other trained health professional can do that during an exam.

Choose the question closest to your concern.

You deserve an answer you can use

Write down anything you still don't understand. Take those questions to the visit with old X-rays and your current pills. Ask again when an answer isn't clear. Before agreeing, you'll want to know what the care involves, what it may cost, and which problems could follow.

Don't let a rushed visit rush your choice.

What does regenerative medicine mean for a sore knee?

Regenerative medicine is a broad name for shots that use blood taken from you, marrow drawn inside a bone, or donated tissue. The name doesn't promise that your knee will improve. Ask exactly what goes into the shot, who gives it, what soreness may follow, and whether any relief is expected to last.

Can worn knee cartilage grow back?

Shots given in a clinic haven't been shown to grow back worn cartilage across the knee. Certain small damaged spots may be repaired with surgery, but that's a different problem. When cartilage repair is mentioned, ask whether it means one small spot or wear throughout the knee.

Does insurance pay for regenerative medicine?

Many plans don't pay for knee shots that use your blood or marrow drawn inside a bone. What your plan pays depends on the exact care. Call the insurer before the visit, then ask the clinic for a written price that includes the shot, later visits, and separate charges, so you aren't surprised at the desk.

Is regenerative knee treatment, such as a blood-based shot, usually cash-pay?

It often is. Ask for a complete written price before scheduling, since the first amount may not include every visit. Get the refund and cancellation terms in writing too. A higher price doesn't mean that a treatment is more likely to help.

How much can regenerative medicine cost in Arizona?

No single price is accurate across all clinics and treatments. The amount isn't fixed; it may depend on what goes into the shot and which later visits are included. Get each charge in writing, then weigh the total against the likely relief and the chance that your knee won't improve.

What happens if home care doesn't settle the soreness?

A doctor or another trained health professional can narrow the likely cause and explain your choices. Expect questions about the ache, a knee exam, and perhaps an X-ray. Take your pill list and earlier reports. If you’re considering a shot, ask what could go wrong, the total cost, and time away from normal activity.

Sources

FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.
FDA's guidance on the 21 CFR 1271.10(a) criteria of MINIMAL MANIPULATION and HOMOLOGOUS USE is the rule that decides whether a cell or tissue product may be offered as a lightly-regulated 'section 361' HCT/P or requires full drug approval as a 'section 351' biologic. Docket FDA-2017-D-6146; the revised July 2020 version extended the agency's period of enforcement discretion through 31 May 2021 - which has now expired, so products outside 361 need an approved application or an active IND.

US Food and Drug Administration, CBER and CDRH — Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. FDA, 2020.
Medicare's National Coverage Determination covers autologous platelet-rich plasma ONLY for chronic non-healing diabetic, pressure or venous WOUNDS, and only under Coverage with Evidence Development inside an approved clinical research study. There is no Medicare coverage pathway for PRP as a treatment for osteoarthritis or any other joint indication, which is why these injections are quoted as cash prices.

Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2012.
The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.
A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.
A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

When the soreness doesn't settle, an exam can help

At QC Kinetix, regenerative treatments are non-surgical shots that use your blood or marrow drawn inside a bone. A medical provider means the trained, licensed health professional who examines your knee and gives the shot at the clinic. There’s no charge for the consultation. The provider can review earlier care and discuss whether an available choice fits you.

PRP begins with blood taken from your arm. It's spun so more platelets collect in the shot. Platelets are tiny blood parts involved in healing. Concentrated PRP contains more of them than regular PRP. Ask how much relief is likely, what could go wrong, how long normal activity may wait, and what you'll pay altogether. The visit can't promise that a shot will help, and you can take the information home.

It’s fine to decide later.

Book a free consultation